Prospective clinical experience with research biopsies in breast cancer patients

Breast Cancer Research and Treatment

Volumn 142, Issue 1, 2013, Pages 203-209

  Vaz Luis, Ines ^a,b   Zeghibe, Catherine A ^a   Frank, Elizabeth S ^a   Sohl, Jessica ^a   Washington, Kimberly E ^c   Silverman, Stuart G ^d   Fonte, Joseph M ^c   Mayer, Erica L ^a   Overmoyer, Beth A ^a   Richardson, Andrea L ^a   Krop, Ian E ^a   Winer, Eric P ^a   Lin, Nancy U ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c Brigham and Women's/Faulkner Hospitals   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer; Patients' preferences; Receptor discordance; Research biopsies

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CANCER RESEARCH; CANCER TISSUE; CAUCASIAN; EXPERIENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAIN; PATIENT SAFETY; PNEUMOTHORAX; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RESEARCH; RISK FACTORS; YOUNG ADULT;

EID: 84888255968     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2717-5     Document Type: Article

References (19)

1. Peppercorn J, Shapira I, Collyar D, Deshields T, Lin N, Krop I, Grunwald H, Friedman P, Partridge AH, Schilsky RL, Bertagnolli MM (2010) Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol 28(15):2635-2640. doi: 10.1200/JCO.2009.27.2443
2. Kodish E, Stocking C, Ratain MJ, Kohrman A, Siegler M (1992) Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons. J Clin Oncol 10(11):1810-1816
3. Olson EM, Lin NU, Krop IE, Winer EP (2011) The ethical use of mandatory research biopsies. Nat Rev Clin Oncol 8(10):620-625. doi: 10.1038/nrclinonc. 2011.114
4. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC (2001) Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 358(9295):1772-1777. doi: 10.1016/S0140-6736(01)06805-2
5. Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, Siegler M (1995) Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13(5):1062-1072
6. Seah DS, Scott SM, Najita J, Openshaw T, Krag K, Frank E, Sohl J, Stadler ZK, Garrett M, Silverman SG, Peppercorn J, Winer EP, Come SE, Lin NU (2013) Attitudes of patients with metastatic breast cancer toward research biopsies. Ann Oncol. doi: 10.1093/annonc/mdt067
7. Pentz RD, Xu Z, Lonial S, Kauh JS, O'Regan RM, Waller EK, Shin DM, Fu H, Khuri F (2008) Research participants' views of nontherapeutic biopsies. ASCO Meet Abstr 26(15):13529
8. Dowlati A, Haaga J, Remick SC, Spiro TP, Gerson SL, Liu L, Berger SJ, Berger NA, Willson JK (2001) Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation. Clin Cancer Res 7(10):2971-2976
9. Brown AP, Wendler DS, Camphausen KA, Miller FG, Citrin D (2008) Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerations. J Clin Oncol 26(24):3987-3994. doi: 10.1200/JCO.2008.16.9896
10. Gomez-Roca CA, Lacroix L, Massard C, De Baere T, Deschamps F, Pramod R, Bahleda R, Deutsch E, Bourgier C, Angevin E, Lazar V, Ribrag V, Koscielny S, Chami L, Lassau N, Dromain C, Robert C, Routier E, Armand JP, Soria JC (2012) Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. Ann Oncol 23(5):1301-1306. doi: 10.1093/annonc/mdr383
11. El-Osta H, Hong D, Wheler J, Fu S, Naing A, Falchook G, Hicks M, Wen S, Tsimberidou AM, Kurzrock R (2011) Outcomes of research biopsies in phase I clinical trials: the MD Anderson cancer center experience. Oncologist 16(9):1292-1298. doi: 10.1634/theoncologist.2011-0043
12. Overman MJ, Modak J, Kopetz S, Murthy R, Yao JC, Hicks ME, Abbruzzese JL, Tam AL (2013) Use of research biopsies in clinical trials: are risks and benefits adequately discussed? J Clin Oncol 31(1):17-22. doi: 10.1200/JCO.2012.43.1718
13. Agulnik M, Oza AM, Pond GR, Siu LL (2006) Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents. J Clin Oncol 24(30):4801-4807. doi: 10.1200/JCO.2005.03.4496
14. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol 5(6):649-655
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373-383
16. Pusztai L, Viale G, Kelly CM, Hudis CA (2010) Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis. Oncologist 15(11):1164-1168. doi: 10.1634/theoncologist.2010-0059
17. Wagle N, Emery C, Berger MF, Davis MJ, Sawyer A, Pochanard P, Kehoe SM, Johannessen CM, Macconaill LE, Hahn WC, Meyerson M, Garraway LA (2011) Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. J Clin Oncol 29(22):3085-3096. doi: 10.1200/JCO.2010.33.2312
18. Peppercorn J (2013) Toward improved understanding of the ethical and clinical issues surrounding mandatory research biopsies. J Clin Oncol 31(1):1-2. doi: 10.1200/JCO.2012.44.8589
19. Emanuel EJ, Wendler D, Grady C (2000) What makes clinical research ethical? J Am Med Assoc 283(20):2701-2711